Daniel Stelzl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Daniel Stelzl has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Putnam Cole
Brigham and Women’s Hospital
7 shared publications - Quoc-Dien Trinh
Department of Urology, University of Pittsburgh, Pittsburgh, PA
7 shared publications - Zhiyu Qian
Department of Urology, Harvard Medical School Brigham and Women's Hospital Boston Massachusetts USA
7 shared publications - Filippo Dagnino
Department of Urology Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Urology, Humanitas Research Hospital - IRCCS, Milan, Italy; Department of Biomedical Sciences, Humanitas University - Milan, Italy
6 shared publications - Hanna Zurl
Department of Urology Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Urology, Medical University of Graz, Graz, Austria
6 shared publications - Klara Pohl
Department of Urology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
4 shared publications
Latest Publications
- 30 October 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-10
Robotic versus open radical cystectomy: factors influencing approach Selection, predictors of surgical Conversion and their implications for patient outcomes
- 30 October 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-10
Robotic versus open radical cystectomy: factors influencing approach Selection, predictors of surgical Conversion and their implications for patient outcomes
- Open Access
Association of Travel Burden with Definitive Prostate Cancer Treatment: A United States Registry Cohort Study
Purpose: Prostate cancer (PCa) mortality disparities are partly driven by unequal access to care. Transportation barriers may limit access to definitive treatment. We studied how driving travel time affects receipt of definitive PCa treatment. Materials and Methods: We conducted a cohort study of men with non-metastatic PCa (2000 - 2015; follow-up through 2018) across the metropolitan area cancer registries of seven US states. Travel burden was estimated using Google Maps isochrones representing driving time thresholds to reach the hospital appended to geomasked residential addresses. Outcomes were “no treatment, “ “radical surgery,” or “radiotherapy”. Covariate-adjusted multinomial logistic regression with interaction terms assessed modification by sociodemographic factors. Results: The study included 132,939 men, of whom 37.0% received no treatment, 41.0% underwent surgery, and 22.0% received radiotherapy. Longer driving time (≥90 min vs <30 min) was associated with higher radical prostatectomy (aOR: 1.07, 95% CI: 1.03, 1.12), but lower radiotherapy (0.72, 95% CI: 0.69 - 0.76). Subgroup analyses revealed higher surgery associated with longer driving times among those in nSES Q1 (aOR: 1.33, 95% CI: 1.21-1.45) vs Q5 (aOR: 0.94, 95% CI: 0.86-1.04), those in low (aOR: 1.16, 95% CI: 1.09-1.24) vs high (aOR: 1.03, 95% CI: 0.98-1.09) population density areas, and those with regional (aOR: 1.30, 95% CI: 1.14-1.48) vs localized (aOR: 1.05, 95% CI: 1.00 -1.09) disease. Longer driving time was mostly associated with lower odds of radiotherapy across sociodemographic subgroups. Conclusions: Higher travel burden was associated with lower radiotherapy receipt, but greater surgery use in deprived and rural patients, which warrants further investigation.
Open AccessAssociation of Travel Burden with Definitive Prostate Cancer Treatment: A United States Registry Cohort Study
Purpose: Prostate cancer (PCa) mortality disparities are partly driven by unequal access to care. Transportation barriers may limit access to definitive treatment. We studied how driving travel time affects receipt of definitive PCa treatment. Materials and Methods: We conducted a cohort study of men with non-metastatic PCa (2000 - 2015; follow-up through 2018) across the metropolitan area cancer registries of seven US states. Travel burden was estimated using Google Maps isochrones representing driving time thresholds to reach the hospital appended to geomasked residential addresses. Outcomes were “no treatment, “ “radical surgery,” or “radiotherapy”. Covariate-adjusted multinomial logistic regression with interaction terms assessed modification by sociodemographic factors. Results: The study included 132,939 men, of whom 37.0% received no treatment, 41.0% underwent surgery, and 22.0% received radiotherapy. Longer driving time (≥90 min vs <30 min) was associated with higher radical prostatectomy (aOR: 1.07, 95% CI: 1.03, 1.12), but lower radiotherapy (0.72, 95% CI: 0.69 - 0.76). Subgroup analyses revealed higher surgery associated with longer driving times among those in nSES Q1 (aOR: 1.33, 95% CI: 1.21-1.45) vs Q5 (aOR: 0.94, 95% CI: 0.86-1.04), those in low (aOR: 1.16, 95% CI: 1.09-1.24) vs high (aOR: 1.03, 95% CI: 0.98-1.09) population density areas, and those with regional (aOR: 1.30, 95% CI: 1.14-1.48) vs localized (aOR: 1.05, 95% CI: 1.00 -1.09) disease. Longer driving time was mostly associated with lower odds of radiotherapy across sociodemographic subgroups. Conclusions: Higher travel burden was associated with lower radiotherapy receipt, but greater surgery use in deprived and rural patients, which warrants further investigation.
- 9 September 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 58 (4) , 1239-1247
Medicolegal landscape of prostate cancer ablative therapy: a national legal database analysis of malpractice claims (1970–2024)
Background With the advancement of MR-based imaging, prostate cancer ablative therapies have seen increased interest to reduce complications of prostate cancer treatment. Although less invasive, they do carry procedural risks, including rectal injury. To date, the medicolegal aspects of ablative therapy remain underexplored. In this study, we aim to analyze malpractice lawsuits related to prostate cancer ablative therapies using a national legal database. Methods In this retrospective study, we utilized the LexisNexis Database to analyze ablative therapy malpractice lawsuits between 1970 and 2024. We searched for keywords “ablative therapy” “focal therapy” “high-intensity focused ultrasound” “HIFU” “cryotherapy” “cryoablation” “laser” “irreversible electroporation” and “IRE” We excluded cases that did not involve ablative treatment of prostate cancer. We then reviewed cases for treatment method, allegation, claimed liabilities, verdict, and plaintiff award. Results We identified 180 lawsuits using the keywords provided, and 5 cases met inclusion criteria. All five lawsuits involved cryoablation for prostate cancer. The most common precipitating injury was rectal injury (3, 60%). Allegations included negligence (2, 25%), deviation from the standard of care (2, 25%), deliberate indifference (2, 25%), and failure to consent (2, 25%). Verdicts were predominantly favorable to defendants (4, 80%), and one case (20%) resulted in an unknown outcome. Conclusions Ablative therapy had a limited number of lawsuits, with outcomes favorable to surgeons and minimal financial payouts. As ablative therapy continues to gain popularity, urologists must practice proper surgical techniques, conduct thorough informed consent, and exercise excellent patient–provider communication to help minimize the occurrence and impact of litigations involving ablative therapy. These findings may help guide future patient risk counseling and support adjustments in malpractice insurance policies as the use of ablative therapies expands, while also informing physicians and hospital systems considering their adoption or expansion.
- 9 September 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 58 (4) , 1239-1247
Medicolegal landscape of prostate cancer ablative therapy: a national legal database analysis of malpractice claims (1970–2024)
Background With the advancement of MR-based imaging, prostate cancer ablative therapies have seen increased interest to reduce complications of prostate cancer treatment. Although less invasive, they do carry procedural risks, including rectal injury. To date, the medicolegal aspects of ablative therapy remain underexplored. In this study, we aim to analyze malpractice lawsuits related to prostate cancer ablative therapies using a national legal database. Methods In this retrospective study, we utilized the LexisNexis Database to analyze ablative therapy malpractice lawsuits between 1970 and 2024. We searched for keywords “ablative therapy” “focal therapy” “high-intensity focused ultrasound” “HIFU” “cryotherapy” “cryoablation” “laser” “irreversible electroporation” and “IRE” We excluded cases that did not involve ablative treatment of prostate cancer. We then reviewed cases for treatment method, allegation, claimed liabilities, verdict, and plaintiff award. Results We identified 180 lawsuits using the keywords provided, and 5 cases met inclusion criteria. All five lawsuits involved cryoablation for prostate cancer. The most common precipitating injury was rectal injury (3, 60%). Allegations included negligence (2, 25%), deviation from the standard of care (2, 25%), deliberate indifference (2, 25%), and failure to consent (2, 25%). Verdicts were predominantly favorable to defendants (4, 80%), and one case (20%) resulted in an unknown outcome. Conclusions Ablative therapy had a limited number of lawsuits, with outcomes favorable to surgeons and minimal financial payouts. As ablative therapy continues to gain popularity, urologists must practice proper surgical techniques, conduct thorough informed consent, and exercise excellent patient–provider communication to help minimize the occurrence and impact of litigations involving ablative therapy. These findings may help guide future patient risk counseling and support adjustments in malpractice insurance policies as the use of ablative therapies expands, while also informing physicians and hospital systems considering their adoption or expansion.
- Open Access
- 29 January 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (3) , 2525-2534
The influence of familiarity between the surgeon and their assistant on patient outcomes: a prospective observational cohort study
Background: The inverse relationship between increased surgical team familiarity and reduced operative time is established, but its effect on patient outcomes remains uncertain. Materials and methods: A prospective cohort study including operations by attending surgeons between 1 November 2020 and 31 December 2021 across fourteen surgical departments from four French university hospitals. Surgical team familiarity was measured as the cumulative number of previous operations performed by the same dyad of attending and assisting surgeons. Composite of adverse events within 30 days of surgery encompassed major surgical complication, unplanned reoperation, extended ICU stay, and death. We used multivariable generally estimated equations to model the association between patient outcomes and surgical team familiarity, using a logarithmic function. The model considered the clustering of operations within surgeons. Results: Our analysis included 8546 operations by 1109 surgical team dyads, involving 45 attending surgeons and 369 assisting surgeons. We observed a significant inverse association between surgical team familiarity and composite adverse events odds ratio [OR] 0.92 (95% confidence interval [95% CI] 0.87–0.98), major surgical complications OR 0.93 (95% CI 0.88–0.99), and unplanned reoperations OR 0.88 (95% CI 0.78–0.99), with non-significant trends observed for extended ICU stays OR 0.88 (95% CI 0.75–1.04) and deaths OR 0.87 (95% CI 0.74–1.03). Within the first 15 collaborations, this was illustrated by a reduction in the occurrence of composite adverse events from 23.0% (95% CI 22.1%–24.0%) to 16.5% (95% CI 14.1%–18.8%), major surgical complications from 21.3% (95% CI 20.3%–22.2%) to 15.3% (95% CI 13.0%–17.5%), unplanned reoperations from 8.8% (95% CI 8.6%–9.1%) to 5.2% (95%CI 4.2%–6.1%), extended ICU stays from 4.3% (95% CI 4.1%–4.5%) to 3.1% (95% CI 2.0%–4.1%), and deaths from 2.3% (95% CI 2.1%–2.5%) to 1.4% (95% CI 0.9%–1.8%). Conclusions and relevance: This study emphasizes that heightened familiarity among surgical teams is associated with a significant reduction in major adverse events. Building stable operating room teams should be a management priority to enhance patient outcomes.
- 29 January 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (3) , 2525-2534
Open AccessThe influence of familiarity between the surgeon and their assistant on patient outcomes: a prospective observational cohort study
Background: The inverse relationship between increased surgical team familiarity and reduced operative time is established, but its effect on patient outcomes remains uncertain. Materials and methods: A prospective cohort study including operations by attending surgeons between 1 November 2020 and 31 December 2021 across fourteen surgical departments from four French university hospitals. Surgical team familiarity was measured as the cumulative number of previous operations performed by the same dyad of attending and assisting surgeons. Composite of adverse events within 30 days of surgery encompassed major surgical complication, unplanned reoperation, extended ICU stay, and death. We used multivariable generally estimated equations to model the association between patient outcomes and surgical team familiarity, using a logarithmic function. The model considered the clustering of operations within surgeons. Results: Our analysis included 8546 operations by 1109 surgical team dyads, involving 45 attending surgeons and 369 assisting surgeons. We observed a significant inverse association between surgical team familiarity and composite adverse events odds ratio [OR] 0.92 (95% confidence interval [95% CI] 0.87–0.98), major surgical complications OR 0.93 (95% CI 0.88–0.99), and unplanned reoperations OR 0.88 (95% CI 0.78–0.99), with non-significant trends observed for extended ICU stays OR 0.88 (95% CI 0.75–1.04) and deaths OR 0.87 (95% CI 0.74–1.03). Within the first 15 collaborations, this was illustrated by a reduction in the occurrence of composite adverse events from 23.0% (95% CI 22.1%–24.0%) to 16.5% (95% CI 14.1%–18.8%), major surgical complications from 21.3% (95% CI 20.3%–22.2%) to 15.3% (95% CI 13.0%–17.5%), unplanned reoperations from 8.8% (95% CI 8.6%–9.1%) to 5.2% (95%CI 4.2%–6.1%), extended ICU stays from 4.3% (95% CI 4.1%–4.5%) to 3.1% (95% CI 2.0%–4.1%), and deaths from 2.3% (95% CI 2.1%–2.5%) to 1.4% (95% CI 0.9%–1.8%). Conclusions and relevance: This study emphasizes that heightened familiarity among surgical teams is associated with a significant reduction in major adverse events. Building stable operating room teams should be a management priority to enhance patient outcomes.
- 1 November 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 42 (1) , 1-7
Trend of ambulatory benign prostatic obstruction surgeries during COVID-19 pandemic
Introduction Benign prostatic obstruction (BPO) is one of the most common causes of male lower urinary tract symptoms. Some institutions routinely perform BPO surgeries in ambulatory setting, while others elect for overnight hospitalization. With the COVID-19 pandemic limiting resources and hospital space for elective surgery, we investigated the time trend of ambulatory BPO procedures performed around the COVID-19 outbreak. Methods We identified BPO surgeries from the California State Inpatient and State Ambulatory Surgery Databases between 2018 and 2020. Our primary outcome was the proportion of procedures performed in ambulatory settings with a length of stay of zero days. Univariable and multivariable analyses were performed to analyze factors associated with ambulatory surgery around the COVID-19 outbreak. Spline regression with a knot at the pandemic outbreak was performed to compare time trends pre- and post-pandemic. Results Among 37,148 patients who underwent BPO procedures, 30,067 (80.9%) were ambulatory. Before COVID-19, 80.1% BPO procedures were performed ambulatory, which increased to 83.4% after COVID-19 outbreak (p < 0.001). In multivariable model, BPO procedures performed after COVID-19 outbreak were 1.26 times more likely to be ambulatory (OR 1.26, 95% CI 1.14–1.40, p < 0.0001). Spline curve analysis indicated significantly different trend of change pre- and post-pandemic (p = 0.006). Conclusions We observed a rising trend of BPO surgeries performed in ambulatory setting post-pandemic. It remains to be seen if the observed ambulatory transition remains as we continue to recover from the pandemic.
- 1 November 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 42 (1) , 1-7
Trend of ambulatory benign prostatic obstruction surgeries during COVID-19 pandemic
Introduction Benign prostatic obstruction (BPO) is one of the most common causes of male lower urinary tract symptoms. Some institutions routinely perform BPO surgeries in ambulatory setting, while others elect for overnight hospitalization. With the COVID-19 pandemic limiting resources and hospital space for elective surgery, we investigated the time trend of ambulatory BPO procedures performed around the COVID-19 outbreak. Methods We identified BPO surgeries from the California State Inpatient and State Ambulatory Surgery Databases between 2018 and 2020. Our primary outcome was the proportion of procedures performed in ambulatory settings with a length of stay of zero days. Univariable and multivariable analyses were performed to analyze factors associated with ambulatory surgery around the COVID-19 outbreak. Spline regression with a knot at the pandemic outbreak was performed to compare time trends pre- and post-pandemic. Results Among 37,148 patients who underwent BPO procedures, 30,067 (80.9%) were ambulatory. Before COVID-19, 80.1% BPO procedures were performed ambulatory, which increased to 83.4% after COVID-19 outbreak (p < 0.001). In multivariable model, BPO procedures performed after COVID-19 outbreak were 1.26 times more likely to be ambulatory (OR 1.26, 95% CI 1.14–1.40, p < 0.0001). Spline curve analysis indicated significantly different trend of change pre- and post-pandemic (p = 0.006). Conclusions We observed a rising trend of BPO surgeries performed in ambulatory setting post-pandemic. It remains to be seen if the observed ambulatory transition remains as we continue to recover from the pandemic.